The New News about Lithium: An Underutilized Treatment in the United States

Abstract

Lithium use for the treatment of mood disorders remains quite low, particularly in the United States compared with some European countries. Mogens Schou pioneered the study of lithium for prophylaxis of the recurrent mood disorder and encouraged its greater use. In an effort to further address the appropriate role of this drug, the multiple assets of lithium beyond its well-known antimanic effect are reviewed, and a brief summary of its side effects is outlined. It appears that lithium has positive effects in depression and suicide prevention, cognition, and reducing the incidence of dementia. It increases the length of telomeres and has positive effects in prevention of some medical illnesses. Lithium side-effect burden, especially its association with end-stage renal disease, may be less than many have surmised. New data indicate the importance of long-term prophylaxis after a first manic episode to lessen episode recurrence, allow cognition to recover to normal, and prevent various aspects of illness progression. After a first manic episode, 1 year of randomized treatment with lithium was superior to that of quetiapine, suggesting the importance of having lithium in the treatment regimen. Given the highly recurrent and progressive course of bipolar disorder sometimes even in the face of conventional treatment, the role and enhanced use of lithium deserves reconsideration.

<p>Management of Treatment-Resistant Depression: Challenges and Strategies</p>

“…104 Despite this evidence, and the antisuicidal nature of lithium, 22,47 it continues to be underutilized and under-prescribed. 118…”

Current Status on Pulsed Laser Deposition of Coatings from Animal-Origin Calcium Phosphate Sources

“…Despite its proven efficacy [159], there are reports when lithium administration determined side effects such as thirst and excessive urination, nausea, diarrhea, tremor, weight gain, sexual dysfunction, dermatological effects, and long-term effects on the thyroid gland, kidneys, and parathyroid glands [160]. However, recent studies challenge this negative perception of lithium administration, stating that intoxication occurs only when the concentration is higher than 1.5 mmol/L, and its main adverse effects can be properly monitored and managed [11,[161][162][163].…”

Beyond evidence‐based treatment of bipolar disorder: Rational pragmatic approaches to management

“…Willingness to consistently take the drug trumps other considerations, and one can hope that some of lithium's many other assets would occur at these lower levels, including its anti-suicide effects, increases in hippocampal and cortical volume, prevention of cognitive deterioration, increasing the length of telomeres, and increasing production of stem cells. 16 Lower than usual lithium levels also can have a role at a first or second episode or in a well interval. Gradual dose titration when the agent is first started is can be valuable, as people tend to generalize and extrapolate their experiences, and the first exposure influences people to believe that they do or do not tolerate medicines in general.…”